Yali Wu

431 total citations
14 papers, 352 citations indexed

About

Yali Wu is a scholar working on Molecular Biology, Oncology and Pharmacology. According to data from OpenAlex, Yali Wu has authored 14 papers receiving a total of 352 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 4 papers in Oncology and 3 papers in Pharmacology. Recurrent topics in Yali Wu's work include Ginseng Biological Effects and Applications (6 papers), Drug Transport and Resistance Mechanisms (2 papers) and Barrier Structure and Function Studies (2 papers). Yali Wu is often cited by papers focused on Ginseng Biological Effects and Applications (6 papers), Drug Transport and Resistance Mechanisms (2 papers) and Barrier Structure and Function Studies (2 papers). Yali Wu collaborates with scholars based in China. Yali Wu's co-authors include Shouying Du, Bo Zhao, Zongxi Sun, Pengyue Li, Haiyan Hu, Wanqing Yang, Hai Liu, Jianqiong Yang, Yang Lu and Shaobo Hu and has published in prestigious journals such as Scientific Reports, International Journal of Molecular Sciences and Molecules.

In The Last Decade

Yali Wu

14 papers receiving 349 citations

Peers

Yali Wu
Yi Qiao China
Wan Gong China
Xiaoye Du China
Xuhua Yu China
Yi Qiao China
Yali Wu
Citations per year, relative to Yali Wu Yali Wu (= 1×) peers Yi Qiao

Countries citing papers authored by Yali Wu

Since Specialization
Citations

This map shows the geographic impact of Yali Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yali Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yali Wu more than expected).

Fields of papers citing papers by Yali Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yali Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yali Wu. The network helps show where Yali Wu may publish in the future.

Co-authorship network of co-authors of Yali Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Yali Wu. A scholar is included among the top collaborators of Yali Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yali Wu. Yali Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Li, Weiqiang, Yu Xiong, Yali Yuan, et al.. (2024). A robust and validated LC–MS/MS method for the quantification of ramucirumab in rat and human serum using direct enzymatic digestion without immunoassay. Journal of Chromatography B. 1234. 123991–123991. 3 indexed citations
2.
Wang, Yizhou, Yali Wu, Shichao Zhang, et al.. (2023). Outcomes of Liver Cancer Patients Undergoing Elective Surgery after Recovering from Mild SARS-CoV-2 Omicron Infection: A Retrospective Cohort Study. Cancers. 15(17). 4254–4254. 4 indexed citations
4.
Sun, Zongxi, Huichao Wu, Yali Wu, et al.. (2021). Comparative Analysis of Compatibility Influence on Invigorating Blood Circulation for Combined Use of Panax Notoginseng Saponins and Aspirin Using Metabolomics Approach. Frontiers in Pharmacology. 12. 544002–544002. 11 indexed citations
5.
Wu, Yali, Bo Zhao, Wanqing Yang, et al.. (2020). Novel Pheretima guillelmi-derived antithrombotic protein DPf3: Identification, characterization, in vitro evaluation and antithrombotic mechanisms investigation. International Journal of Biological Macromolecules. 154. 545–556. 24 indexed citations
6.
Liu, Hai, Jianqiong Yang, Wanqing Yang, et al.. (2020). <p>Focus on Notoginsenoside R1 in Metabolism and Prevention Against Human Diseases</p>. Drug Design Development and Therapy. Volume 14. 551–565. 62 indexed citations
7.
Zhang, Yue, Cheng Wang, Yali Wu, et al.. (2019). Network Pharmacology-Based identification of pharmacological mechanism of SQFZ injection in combination with Docetaxel on lung cancer. Scientific Reports. 9(1). 4533–4533. 18 indexed citations
9.
Wu, Yali, Bo Zhao, Wanqing Yang, et al.. (2019). Transcriptomic-proteomics-anticoagulant bioactivity integrated study of Pheretima guillemi. Journal of Ethnopharmacology. 243. 112101–112101. 17 indexed citations
11.
Sun, Zongxi, Yali Wu, Bing Yang, et al.. (2018). Inhibitory Influence of Panax notoginseng Saponins on Aspirin Hydrolysis in Human Intestinal Caco-2 Cells. Molecules. 23(2). 455–455. 13 indexed citations
12.
Sun, Zongxi, Yali Wu, Song Liu, et al.. (2018). Effects of Panax Notoginseng Saponins on Esterases Responsible for Aspirin Hydrolysis In Vitro. International Journal of Molecular Sciences. 19(10). 3144–3144. 14 indexed citations
13.
Chen, Xiaonan, Danqi Li, Shouying Du, et al.. (2017). Pharmacokinetics of Panax notoginseng Saponins in Adhesive and Normal Preparation of Fufang Danshen. European Journal of Drug Metabolism and Pharmacokinetics. 43(2). 215–225. 12 indexed citations
14.
Wu, Yali, et al.. (2017). Aldehyde oxidase-dependent species difference in hepatic metabolism of fasudil to hydroxyfasudil. Xenobiotica. 48(2). 170–177. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026